News

The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)

The light-based therapy functions using a virtual reality headset

Challenging choices force ophthalmologists to weigh long-term outcomes

Inhibiting ferroptosis could be crucial to reducing inflammation

Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress

The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen

For decoding biomarkers, a multistage system is just the beginning

Need for accuracy results in optimisation of training for novice surgeons

The implantable lenses can offer an advantage over laser surgery

Promising innovations are not one-size-fits-all

The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March

Three leaders in glaucoma research, retina care and refractive surgery share their expertise

Astigmatic values differed between K and TK readings

Considering ages and stages of myopia progression in a therapeutic timeline

The mutant huntingtin protein in tear fluid may have the potential to serve as an early marker of changes in Huntington disease

Investigators say children with cortical/cerebral visual impairment experience markedly lower vision-specific quality of life

Study results indicate that maintaining control of blood pressure and hemoglobin A1c are key to preventing the onset of diabetic retinopathy

This study also investigated the development of myopia rebound when dosing was discontinued

Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care

Study data demonstrated a significant correlation between visual function, structure and neurological impairment in an experimental autoimmune encephalomyelitis model

Ahead of the meeting, several companies previewed product pipeline announcements and research data presentations

The meeting kicks off with symposia and an opening keynote speech from Ed Yong

During the month of May, Prevent Blindness will offer fact sheets, videos and other resources for IRD education